[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsPatients in the intervention group were treated with a group of antibiotics with gram-negative and gram-positive coverage (third generation cephalosporin). Third-generation cephalosporins include cefotaxime (from Eixir Pharmaceutical Company) as an injection at a dose of 50 mg per kg every 8 hours for at least 7 days. Also in this group, the routine hospital care intervention intended for the control group included serum therapy (including normal saline serum, one-third and two-thirds serum), and the use of antipyretics (acetaminophen at a dose of 10 mg per kg). It was administered orally or by injection in patients with a body temperature of more than 38 with an interval of at least 6 hours.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIn the control group, patients did not receive any antibiotics and routine hospital care included serum therapy (including normal saline, one-third and two-thirds serum), and the use of antipyretics (acetaminophen at a dose of 10 mg per kg). Received orally or by injection in patients with a body temperature greater than 38 (at least 6 hours apart) during hospitalization.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2436, "treatment_name": "Cefotaxime", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]